ANTIVIRAL COMPOSITIONS
    1.
    发明申请
    ANTIVIRAL COMPOSITIONS 审中-公开
    有害成分

    公开(公告)号:US20070196478A1

    公开(公告)日:2007-08-23

    申请号:US11733507

    申请日:2007-04-10

    摘要: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

    摘要翻译: 本发明涉及可以施用于患有病毒感染的哺乳动物,特别是人的抗病毒化合物的药物组合物。 这些组合物包含通过熔融挤出包含一种或多种抗病毒化合物和一种或多种合适的水溶性聚合物的混合物并随后研磨所述熔融挤出的混合物而获得的颗粒。

    Antiviral compositions
    3.
    发明授权
    Antiviral compositions 有权
    抗病毒组合物

    公开(公告)号:US07887845B2

    公开(公告)日:2011-02-15

    申请号:US11347071

    申请日:2006-02-03

    IPC分类号: A61K9/14

    摘要: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

    摘要翻译: 本发明涉及可以施用于患有病毒感染的哺乳动物,特别是人的抗病毒化合物的药物组合物。 这些组合物包含通过熔融挤出包含一种或多种抗病毒化合物和一种或多种合适的水溶性聚合物的混合物并随后研磨所述熔融挤出的混合物而获得的颗粒。

    Antiviral compositions
    4.
    发明申请
    Antiviral compositions 有权
    抗病毒组合物

    公开(公告)号:US20060127487A1

    公开(公告)日:2006-06-15

    申请号:US11347071

    申请日:2006-02-03

    IPC分类号: A61K9/14 A61K31/53 A61K31/506

    摘要: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

    摘要翻译: 本发明涉及可以施用于患有病毒感染的哺乳动物,特别是人的抗病毒化合物的药物组合物。 这些组合物包含通过熔融挤出包含一种或多种抗病毒化合物和一种或多种合适的水溶性聚合物的混合物并随后研磨所述熔融挤出的混合物而获得的颗粒。

    Coating technique for deposition of drug substance on a substrate
    7.
    发明申请
    Coating technique for deposition of drug substance on a substrate 审中-公开
    用于在基材上沉积药物的涂覆技术

    公开(公告)号:US20050158385A1

    公开(公告)日:2005-07-21

    申请号:US11077680

    申请日:2005-03-11

    摘要: The present invention relates to a multi-layered, physiologically tolerated oral dosage form for pharmaceutically active compounds. The dosage form comprises a central core, a middle layer, and an outer shell, at least one of which includes at least one pharmaceutically active substance. By varying the diameter of the core, a different middle layer volume is obtained within a fixed outer shell dimension. This gives the ability to obtain different dosage strengths for one composition without the need of reformulation work. The oral dosage form is produced in a single-step, continuous process by coating the core with the middle layer and the outer shell.

    摘要翻译: 本发明涉及用于药物活性化合物的多层生理耐受的口服剂型。 剂型包含中心核心,中间层和外壳,其中至少一个包括至少一种药物活性物质。 通过改变芯的直径,在固定的外壳尺寸内获得不同的中间层体积。 这使得能够为一种组合物获得不同的剂量强度,而不需要重新配制工作。 口服剂型通过用中间层和外壳涂覆核心,以单步连续方法生产。

    Compositions of lipid lowering agents
    8.
    发明授权
    Compositions of lipid lowering agents 失效
    降脂剂组合物

    公开(公告)号:US06342245B1

    公开(公告)日:2002-01-29

    申请号:US09530170

    申请日:2000-04-24

    IPC分类号: A61K948

    CPC分类号: A61K9/146

    摘要: The present invention is concerned with novel pharmaceutical compositions of lipid lowering agents which can be administered to a mammal suffering from hyperlipidemia, obesitas or atherosclerosis, whereby a single such dosage form can be administered once daily, and in addition at any time of the day independently of the food taken in by said mammal. These novel compositions comprise particles obtainable by melt-extruding a mixture comprising a lipid lowering agent and an appropriate water-soluble polymer and subsequently milling said melt-extruded mixture.

    摘要翻译: 本发明涉及可以向患有高脂血症,肥胖或动脉粥样硬化的哺乳动物施用的降脂药的新型药物组合物,由此可以每天一次施用单一的这种剂型,另外在一天中的任何时间独立地施用 的哺乳动物摄入的食物。 这些新型组合物包含通过熔融挤出包含降脂剂和合适的水溶性聚合物的混合物并随后研磨所述熔融挤出的混合物而获得的颗粒。

    Antiviral compositions
    10.
    发明授权
    Antiviral compositions 有权
    抗病毒组合物

    公开(公告)号:US07241458B1

    公开(公告)日:2007-07-10

    申请号:US10088805

    申请日:2000-08-31

    摘要: The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.

    摘要翻译: 本发明涉及可以施用于患有病毒感染的哺乳动物,特别是人的抗病毒化合物的药物组合物。 这些组合物包含通过熔融挤出包含一种或多种抗病毒化合物和一种或多种合适的水溶性聚合物的混合物并随后研磨所述熔融挤出的混合物而获得的颗粒。